The stuff app makers hoped you wouldn't notice

Within eight months the conversational coach went from novelty to table stakes across every major platform. The evidence base did not move at all.

An FTC intervention on tracking-technology consent, new HIPAA rules and a wave of state sensitive-health-data laws are converging on the same practice: the advertising pixel quietly sitting inside a health flow.

The mental-health app category spent a decade asking to be treated as software. In 2026 it started being treated as care — state by state, with very different rules in each.

The complaint pairs the two failures we log most often — advertising trackers on sensitive health data, and a subscription you can't easily leave — and puts them in front of a federal judge.

Small money, useful direction. In the same year the agency stepped back from regulating wearables, it started paying for evidence about them.

Sleep and recovery hardware is consolidating fast. That's good for buyers in the short run and worth watching in the long one.

A ten-billion-dollar valuation on a business with no hardware revenue is a bet on one number: how long people keep paying. That bet has a predictable effect on product design.

Within roughly eight weeks the calorie-scanning app was acquired, breached, and removed from the App Store over its own paywall design. Each event is ordinary. Together they describe a set of priorities.

Passive screening at consumer scale is arriving quietly. It's a genuinely useful capability with a specific limitation that the marketing doesn't lead with.

A January guidance shift means many wearables and AI health tools can reach the market without formal device review. The claims get looser; the burden of verifying them moves outward.